Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ENDRA Life Sciences (NDRA) Other Non Operating Income (2017 - 2025)

ENDRA Life Sciences has reported Other Non Operating Income over the past 6 years, most recently at -$350145.0 for Q4 2021.

  • Quarterly Other Non Operating Income changed N/A to -$350145.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$49052.0 through Dec 2021, down 1327.53% year-over-year, with the annual reading at $3.1 million for FY2024, 568.14% up from the prior year.
  • Other Non Operating Income was -$350145.0 for Q4 2021 at ENDRA Life Sciences, down from -$7507.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $308600.0 in Q1 2021 and troughed at -$380926.0 in Q1 2017.
  • The 5-year median for Other Non Operating Income is -$8353.0 (2019), against an average of -$36422.6.
  • Year-over-year, Other Non Operating Income plummeted 6225.57% in 2017 and then surged 4563.74% in 2021.
  • A 5-year view of Other Non Operating Income shows it stood at $1931.0 in 2017, then crashed by 979.85% to -$16990.0 in 2018, then crashed by 203.56% to -$51575.0 in 2019, then soared by 94.92% to -$2621.0 in 2020, then tumbled by 13259.21% to -$350145.0 in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Other Non Operating Income are -$350145.0 (Q4 2021), -$7507.0 (Q3 2021), and $308600.0 (Q1 2021).